Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-Phospho-EGF Receptor (Tyr1173) Antibody (9B499) is a Rabbit antibody targeting Phospho-EGF Receptor (Tyr1173). Anti-Phospho-EGF Receptor (Tyr1173) Antibody (9B499) can be used in WB.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 20 μL | $80 | 7-10 days | |
| 100 μL | $233 | 7-10 days |
| Description | Anti-Phospho-EGF Receptor (Tyr1173) Antibody (9B499) is a Rabbit antibody targeting Phospho-EGF Receptor (Tyr1173). Anti-Phospho-EGF Receptor (Tyr1173) Antibody (9B499) can be used in WB. |
| Synonyms | PIG61, Phospho-EGF Receptor (Y1173), p-EGF Receptor (Y1173), p-EGF Receptor (Tyr1173), NISBD2, mENA, HER-1, HER1, ERRP, ERBB-1, ERBB1, ERBB, EGF Receptor (p-Y1173), EGF Receptor (p-Tyr1173) |
| Ig Type | Rabbit IgG |
| Clone | 9B499 |
| Reactivity | Human;
Species predicted to react based on 100% sequence homology: cynomolgus |
| Specificity | Human
Species predicted to react based on 100% sequence homology: cynomolgus |
| Verified Activity | 1. Western blot analysis of extracts from serum-starved Hela, untreated (-) or treated with EGF using Phospho-EGF Receptor (Tyr1173) rabbit monoclonal Antibody at 1:5000 dilution (upper), or Anti-EGFR Antibody, Rabbit Polyclonal at 1:2000 dilution (lower).
2. Western blot analysis of extracts from serum-starved Hela, untreated (line A); treated with EGF using Phospho-EGF Receptor (Tyr1173) rabbit monoclonal Antibody at 1:10000 dilution. (Validation Experiment) |
| Application | |
| Recommended Dose | WB: 1:5000-1:50000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with a synthetic phosphopeptide corresponding to residues around Tyr1173 of the Human Phospho-EGF Receptor. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 10 mM sodium HEPES, 150 mM NaCl, 100 μg/mL BSA, 50% glycerol, pH 7.5 |
| Research Background | As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-α, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | Unconjugated |
| Immunogen | A synthetic peptide: residues around Tyr1173 of the Human Phospho-EGF Receptor |
| Antigen Species | Human |
| Biology Area | Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs) |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.